Clinical Trials in Texas

Showing 8901-8920 of 15,101 trials

Nitrous Oxide for Analgesia During Office Urethral Bulking

NCT03847922

This study is designed to determine primarily if there is a difference in perceived pain in patients receiving urethral bulking with calcium hydroxylapatite using local lidocaine versus local lidocaine plus nitrous oxide gas. Patients will be randomized to a control group (local lidocaine plus room air) or a intervention group (local lidocaine plus 50% nitrous oxide/50% oxygen inhaled mixture). Their pain will be assessed immediately after the procedure, and their recollection of pain will also be assessed at their 2 week post-procedure visit. There are other secondary outcome measures as well; please see outcome measures section for full description.

PainStress Incontinence, Female

Baylor Research Institute2 participantsStarted Feb 2019

Temple, Texas, United States

COMPLETEDPhase 242 miles

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

NCT01218516

The primary objective of this study is to compare the effect of farletuzumab versus placebo in combination with either a platinum agent (carboplatin) with paclitaxel or a platinum agent (carboplatin or cisplatin) with pemetrexed followed by farletuzumab or placebo on investigator-assessed progression free survival (PFS) as determined by Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1 or definitive clinical disease progression (eg, new occurrence of positive fluid cytology) in chemotherapy naive participants with folate receptoralpha (FRA)-expressing Stage IV adenocarcinoma of the lung.

Adenocarcinoma of the Lung

Morphotek130 participantsStarted Jun 2011

Chandler, Arizona, United States • Glendale, Arizona, United States • Beverly Hills, California, United States +90 more locations

Nitrous Oxide for Analgesia During Office Urethral Bulking

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Find Trials by Condition in Texas

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

AMG 827 in Subjects With Psoriatic Arthritis

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05